Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label single-arm study of SYHX2011 in advanced breast cancer
CTR20241186Phase 2Active
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of SYHX-2011 in breast cancer, sponsored by CSPC Ouyi Pharmaceutical. Started Apr 2024; status: active.
02
Drugs
SYHX-2011
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20241186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241186.